Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Amedisys Inc Lowers FY 2012 Revenue Guidance; Narrows FY 2012 EPS Guidance To A Range In Line With Analysts' Estimates


Tuesday, 6 Nov 2012 07:00am EST 

Amedisys Inc announced that for fiscal 2012, it expects net service revenue to be in the range of $1.485 billion to $1.505 billion and diluted earnings per share (EPS) to be in the range of $1.00 to $1.06. This guidance excludes the effects of any future acquisitions, if any are made, any costs associated with the closing of our new credit agreement or any severance related charges. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.510 billion and EPS of $1.01 for fiscal 2012. 

Company Quote

15.72
0.23 +1.48%
11 Jul 2014